| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | olfactory receptor activity | OR11H4 OR4D9 OR4E2 OR4D1 OR4D11 OR4D2 OR6V1 OR10G2 OR4A5 OR4A16 OR4K1 | 2.85e-05 | 431 | 111 | 11 | GO:0004984 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | ASIC1 OR11H4 OR4D9 OR4E2 OR4D1 OR4D11 OR4D2 OR6V1 OR10G2 OR4A5 OR4A16 OR4K1 SCNN1G | 8.61e-06 | 547 | 112 | 13 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR11H4 OR4D9 OR4E2 OR4D1 OR4D11 OR4D2 OR6V1 OR10G2 OR4A5 OR4A16 OR4K1 | 2.36e-05 | 432 | 112 | 11 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR11H4 OR4D9 OR4E2 OR4D1 OR4D11 OR4D2 OR6V1 OR10G2 OR4A5 OR4A16 OR4K1 | 4.61e-05 | 465 | 112 | 11 | GO:0007608 |
| GeneOntologyBiologicalProcess | sensory perception | CFH CACNA1D ASIC1 OR11H4 OR4D9 OR4E2 OR4D1 OR4D11 OR4D2 OR6V1 OR10G2 OR4A5 OR4A16 OR4K1 PCDH15 SCNN1G TRPM8 | 6.54e-05 | 1072 | 112 | 17 | GO:0007600 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR11H4 OR4D9 OR4E2 OR4D1 OR4D11 OR4D2 OR6V1 OR10G2 OR4A5 OR4A16 OR4K1 | 6.72e-05 | 485 | 112 | 11 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR11H4 OR4D9 OR4E2 OR4D1 OR4D11 OR4D2 OR6V1 OR10G2 OR4A5 OR4A16 OR4K1 PCDH15 | 7.72e-05 | 582 | 112 | 12 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR11H4 OR4D9 OR4E2 OR4D1 OR4D11 OR4D2 OR6V1 OR10G2 OR4A5 OR4A16 OR4K1 | 1.33e-04 | 524 | 112 | 11 | GO:0009593 |
| Domain | Olfact_rcpt | OR11H4 OR4D9 OR4E2 OR4D1 OR4D11 OR4D2 OR6V1 OR10G2 OR4A5 OR4A16 OR4K1 | 2.65e-05 | 393 | 113 | 11 | IPR000725 |
| Domain | Arp3_met | 1.08e-04 | 3 | 113 | 2 | IPR015623 | |
| Domain | CAC1F_C | 1.08e-04 | 3 | 113 | 2 | IPR031688 | |
| Domain | CAC1F_C | 1.08e-04 | 3 | 113 | 2 | PF16885 | |
| Domain | GPCR_Rhodpsn_7TM | OR11H4 OR4D9 OR4E2 OR4D1 OR4D11 SSTR3 OR4D2 LHCGR OR6V1 OR10G2 OR4A5 OR4A16 OR4K1 | 2.06e-04 | 670 | 113 | 13 | IPR017452 |
| Domain | FAM86 | 2.16e-04 | 4 | 113 | 2 | PF14904 | |
| Domain | FAM86 | 2.16e-04 | 4 | 113 | 2 | IPR029426 | |
| Domain | VDCC_L_a1su | 2.16e-04 | 4 | 113 | 2 | IPR005446 | |
| Domain | 7tm_1 | OR11H4 OR4D9 OR4E2 OR4D1 OR4D11 SSTR3 OR4D2 LHCGR OR6V1 OR10G2 OR4A5 OR4A16 OR4K1 | 2.28e-04 | 677 | 113 | 13 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR11H4 OR4D9 OR4E2 OR4D1 OR4D11 SSTR3 OR4D2 LHCGR OR6V1 OR10G2 OR4A5 OR4A16 OR4K1 | 2.56e-04 | 685 | 113 | 13 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR11H4 OR4D9 OR4E2 OR4D1 OR4D11 SSTR3 OR4D2 LHCGR OR6V1 OR10G2 OR4A5 OR4A16 OR4K1 | 2.78e-04 | 691 | 113 | 13 | PS50262 |
| Domain | GPCR_Rhodpsn | OR11H4 OR4D9 OR4E2 OR4D1 OR4D11 SSTR3 OR4D2 LHCGR OR6V1 OR10G2 OR4A5 OR4A16 OR4K1 | 2.82e-04 | 692 | 113 | 13 | IPR000276 |
| Domain | ProC_N | 7.47e-04 | 7 | 113 | 2 | IPR028939 | |
| Domain | ENaC | 7.47e-04 | 7 | 113 | 2 | IPR004724 | |
| Domain | VDCC_a1su_IQ | 7.47e-04 | 7 | 113 | 2 | IPR014873 | |
| Domain | GPHH | 7.47e-04 | 7 | 113 | 2 | PF16905 | |
| Domain | F420_oxidored | 7.47e-04 | 7 | 113 | 2 | PF03807 | |
| Domain | GPHH_dom | 7.47e-04 | 7 | 113 | 2 | IPR031649 | |
| Domain | Ca_chan_IQ | 7.47e-04 | 7 | 113 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 7.47e-04 | 7 | 113 | 2 | PF08763 | |
| Domain | Na+channel_ASC_CS | 9.92e-04 | 8 | 113 | 2 | IPR020903 | |
| Domain | ASC | 1.27e-03 | 9 | 113 | 2 | PF00858 | |
| Domain | ASC | 1.27e-03 | 9 | 113 | 2 | PS01206 | |
| Domain | Na+channel_ASC | 1.27e-03 | 9 | 113 | 2 | IPR001873 | |
| Domain | VDCCAlpha1 | 1.58e-03 | 10 | 113 | 2 | IPR002077 | |
| Domain | Methyltransf_16 | 1.93e-03 | 11 | 113 | 2 | IPR019410 | |
| Domain | Methyltransf_16 | 1.93e-03 | 11 | 113 | 2 | PF10294 | |
| Domain | AA_permease_2 | 2.71e-03 | 13 | 113 | 2 | PF13520 | |
| Domain | AA/rel_permease1 | 2.71e-03 | 13 | 113 | 2 | IPR002293 | |
| Domain | Helicase_C | 4.06e-03 | 107 | 113 | 4 | PF00271 | |
| Domain | HELICc | 4.06e-03 | 107 | 113 | 4 | SM00490 | |
| Domain | Helicase_C | 4.20e-03 | 108 | 113 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 4.34e-03 | 109 | 113 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 4.34e-03 | 109 | 113 | 4 | PS51192 | |
| Domain | DEXDc | 4.34e-03 | 109 | 113 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 4.48e-03 | 110 | 113 | 4 | IPR014001 | |
| Domain | Actin/actin-like_CS | 5.21e-03 | 18 | 113 | 2 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 5.80e-03 | 19 | 113 | 2 | PS01132 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR11H4 OR4D9 OR4E2 OR4D1 OR4D11 OR4D2 OR6V1 OR10G2 OR4A5 OR4A16 OR4K1 | 3.25e-05 | 389 | 89 | 11 | M14091 |
| Pathway | REACTOME_SENSORY_PERCEPTION | CACNA1D OR11H4 OR4D9 OR4E2 OR4D1 OR4D11 OR4D2 OR6V1 OR10G2 OR4A5 OR4A16 OR4K1 PCDH15 SCNN1G | 4.17e-05 | 636 | 89 | 14 | M41834 |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR11H4 OR4D9 OR4E2 OR4D1 OR4D11 OR4D2 OR6V1 OR10G2 OR4A5 OR4A16 OR4K1 | 6.10e-05 | 417 | 89 | 11 | M4072 |
| Pathway | SIG_CHEMOTAXIS | 1.81e-04 | 45 | 89 | 4 | M5193 | |
| Pubmed | OR11H4 OR4D9 OR4E2 OR4D1 OR4D11 OR4D2 OR6V1 OR10G2 OR4A5 OR4A16 OR4K1 | 1.93e-06 | 541 | 115 | 11 | 14983052 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | 2.08e-06 | 340 | 115 | 9 | 11875048 | |
| Pubmed | 2.08e-06 | 340 | 115 | 9 | 11802173 | ||
| Pubmed | 2.23e-06 | 343 | 115 | 9 | 32295537 | ||
| Pubmed | 2.40e-06 | 346 | 115 | 9 | 14611657 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 21054386 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 24086669 | ||
| Pubmed | Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3. | 1.08e-05 | 2 | 115 | 2 | 26049024 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 19225208 | ||
| Pubmed | Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. | 1.08e-05 | 2 | 115 | 2 | 16706838 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 23761887 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 14981074 | ||
| Pubmed | CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum. | 1.08e-05 | 2 | 115 | 2 | 25292336 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 17526649 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 12606379 | ||
| Pubmed | Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators. | 1.08e-05 | 2 | 115 | 2 | 24941892 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 22826131 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 24470632 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 24760982 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 20014384 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 30001160 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 21352396 | ||
| Pubmed | Molecular nature of anomalous L-type calcium channels in mouse cerebellar granule cells. | 1.08e-05 | 2 | 115 | 2 | 17409250 | |
| Pubmed | Neuronal L-type calcium channels open quickly and are inhibited slowly. | 1.08e-05 | 2 | 115 | 2 | 16267232 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 10806390 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 24996399 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 24849370 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 17015854 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 24848473 | ||
| Pubmed | Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo. | 1.08e-05 | 2 | 115 | 2 | 15749874 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 17767505 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 2173707 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 26831068 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 23338940 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 19561078 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 19351867 | ||
| Pubmed | Truncation of murine CaV1.2 at Asp-1904 results in heart failure after birth. | 3.24e-05 | 3 | 115 | 2 | 21832054 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 17289261 | ||
| Pubmed | Potent inhibition of L-type Ca2+ currents by a Rad variant associated with congestive heart failure. | 3.24e-05 | 3 | 115 | 2 | 23973784 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 34611166 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 31302118 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 23045342 | ||
| Pubmed | Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons. | 3.24e-05 | 3 | 115 | 2 | 24934288 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 27190058 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 20937870 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 18212277 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 12429845 | ||
| Pubmed | USP38 Couples Histone Ubiquitination and Methylation via KDM5B to Resolve Inflammation. | 6.48e-05 | 4 | 115 | 2 | 33240782 | |
| Pubmed | WAVE and Arp2/3 jointly inhibit filopodium formation by entering into a complex with mDia2. | 6.48e-05 | 4 | 115 | 2 | 18516090 | |
| Pubmed | Molecular coupling of a Ca2+-activated K+ channel to L-type Ca2+ channels via alpha-actinin2. | 6.48e-05 | 4 | 115 | 2 | 17110593 | |
| Pubmed | Adult-onset Alopecia areata is a complex polygenic trait in the C3H/HeJ mouse model. | 6.78e-05 | 24 | 115 | 3 | 15245428 | |
| Pubmed | 1.08e-04 | 5 | 115 | 2 | 10563804 | ||
| Pubmed | A conserved amphipathic helix in WASP/Scar proteins is essential for activation of Arp2/3 complex. | 1.08e-04 | 5 | 115 | 2 | 12872157 | |
| Pubmed | 1.08e-04 | 5 | 115 | 2 | 11296258 | ||
| Pubmed | 1.08e-04 | 5 | 115 | 2 | 21697455 | ||
| Pubmed | Local and cis effects of the H element on expression of odorant receptor genes in mouse. | 1.08e-04 | 5 | 115 | 2 | 17662950 | |
| Pubmed | 1.08e-04 | 5 | 115 | 2 | 12874215 | ||
| Pubmed | FAM86A methylation of eEF2 links mRNA translation elongation to tumorigenesis. | 1.08e-04 | 5 | 115 | 2 | 38508183 | |
| Pubmed | 1.08e-04 | 5 | 115 | 2 | 12829704 | ||
| Pubmed | 1.08e-04 | 5 | 115 | 2 | 15451373 | ||
| Pubmed | 1.08e-04 | 5 | 115 | 2 | 11049973 | ||
| Pubmed | 1.08e-04 | 5 | 115 | 2 | 31663850 | ||
| Pubmed | 1.08e-04 | 5 | 115 | 2 | 9864144 | ||
| Pubmed | Control of in vivo collateral damage generated by T cell immunity. | 1.08e-04 | 5 | 115 | 2 | 23851694 | |
| Pubmed | Integration of multiple signals through cooperative regulation of the N-WASP-Arp2/3 complex. | 1.08e-04 | 5 | 115 | 2 | 11052943 | |
| Pubmed | Voltage-gated calcium channels in developing GnRH-1 neuronal system in the mouse. | 1.61e-04 | 6 | 115 | 2 | 16029198 | |
| Pubmed | 1.61e-04 | 6 | 115 | 2 | 21224388 | ||
| Pubmed | 1.61e-04 | 6 | 115 | 2 | 23734214 | ||
| Pubmed | The growth factor granulin interacts with cyclin T1 and modulates P-TEFb-dependent transcription. | 1.61e-04 | 6 | 115 | 2 | 12588988 | |
| Pubmed | 1.61e-04 | 6 | 115 | 2 | 16615932 | ||
| Pubmed | 1.79e-04 | 33 | 115 | 3 | 19336002 | ||
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 1.81e-04 | 157 | 115 | 5 | 30686591 | |
| Pubmed | 2.25e-04 | 7 | 115 | 2 | 12900400 | ||
| Pubmed | 2.25e-04 | 7 | 115 | 2 | 9889097 | ||
| Pubmed | 2.43e-04 | 371 | 115 | 7 | 15747579 | ||
| Pubmed | 3.00e-04 | 8 | 115 | 2 | 10381382 | ||
| Pubmed | 3.00e-04 | 8 | 115 | 2 | 26975831 | ||
| Pubmed | Clonal deletion and the fate of autoreactive thymocytes that survive negative selection. | 3.00e-04 | 8 | 115 | 2 | 22544394 | |
| Pubmed | Interaction of WASP/Scar proteins with actin and vertebrate Arp2/3 complex. | 3.00e-04 | 8 | 115 | 2 | 11146629 | |
| Pubmed | ILC2s regulate adaptive Th2 cell functions via PD-L1 checkpoint control. | 3.84e-04 | 9 | 115 | 2 | 28747424 | |
| Pubmed | 4.23e-04 | 44 | 115 | 3 | 19322198 | ||
| Pubmed | The human ATP-binding cassette (ABC) transporter superfamily. | 4.79e-04 | 10 | 115 | 2 | 11435397 | |
| Pubmed | 4.82e-04 | 46 | 115 | 3 | 32126975 | ||
| Pubmed | 5.85e-04 | 11 | 115 | 2 | 18809727 | ||
| Pubmed | 7.00e-04 | 12 | 115 | 2 | 9110172 | ||
| Pubmed | 7.00e-04 | 12 | 115 | 2 | 26813283 | ||
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | 8.28e-04 | 219 | 115 | 5 | 12213199 | |
| Pubmed | 9.61e-04 | 14 | 115 | 2 | 20854876 | ||
| Pubmed | 1.11e-03 | 15 | 115 | 2 | 19536649 | ||
| Pubmed | 1.11e-03 | 15 | 115 | 2 | 20188150 | ||
| Pubmed | 1.11e-03 | 15 | 115 | 2 | 24453333 | ||
| Pubmed | 1.13e-03 | 777 | 115 | 9 | 35844135 | ||
| Pubmed | 1.26e-03 | 16 | 115 | 2 | 20301753 | ||
| Pubmed | 1.27e-03 | 64 | 115 | 3 | 22261194 | ||
| Pubmed | FRAS1 MCMBP DNAJC6 THOC5 UBXN4 PTPN13 NDC1 DNAJC10 BRI3BP NUP133 STEAP3 SLC39A6 COL14A1 | 1.29e-03 | 1487 | 115 | 13 | 33957083 | |
| Pubmed | The interactome of the prostate-specific protein Anoctamin 7. | 1.32e-03 | 65 | 115 | 3 | 32176628 | |
| Pubmed | 1.33e-03 | 143 | 115 | 4 | 20424473 | ||
| Pubmed | Calcium handling precedes cardiac differentiation to initiate the first heartbeat. | 1.43e-03 | 17 | 115 | 2 | 27725084 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 1.47e-03 | 807 | 115 | 9 | 30575818 | |
| Pubmed | 1.55e-03 | 149 | 115 | 4 | 22664934 | ||
| Cytoband | 14q11.2 | 9.49e-05 | 180 | 115 | 5 | 14q11.2 | |
| GeneFamily | Olfactory receptors, family 4 | 1.02e-07 | 129 | 80 | 8 | 151 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 1.04e-03 | 11 | 80 | 2 | 1168 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-08 | 169 | 115 | 8 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.72e-07 | 199 | 115 | 7 | 6200618e029063486719479c41eaf31798bd13cf | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.95e-07 | 125 | 115 | 6 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.04e-06 | 162 | 115 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.38e-06 | 184 | 115 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.38e-06 | 184 | 115 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.38e-06 | 184 | 115 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-06 | 187 | 115 | 6 | c81d11d9fdc22dc39222f62c2888025c2e8c3e65 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.77e-06 | 189 | 115 | 6 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-05 | 194 | 115 | 6 | 2f6e62a4ec8707bd5a16c0734c5131af55207ea2 | |
| ToppCell | facs-Heart-LA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 196 | 115 | 6 | 8a84aeb1a565dd3e2a690fcaf1ab804f5e253545 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 196 | 115 | 6 | ad1838dabd043cb140260843e3527d8c7d58850e | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 196 | 115 | 6 | cbc15c0769016fe9972445169029bd8d14a7e6ef | |
| ToppCell | distal-Epithelial-Club-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.31e-05 | 199 | 115 | 6 | 685cefbe6ff5db8b578e50b5849524ac2f347d0c | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 200 | 115 | 6 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 145 | 115 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.30e-05 | 156 | 115 | 5 | abea3c183d32062b009a79a2bdf861021989c7ef | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.72e-05 | 164 | 115 | 5 | 6fb2136168f430babfeb81ca7e151ca7a8092ec4 | |
| ToppCell | Healthy_Control-Lymphoid-T-innate_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 6.92e-05 | 165 | 115 | 5 | 1ade67229b50fe20eb392262a3e1ee4306b73290 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.12e-05 | 166 | 115 | 5 | 545f6c91102568791443717e522f89cb3bd1a070 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.53e-05 | 168 | 115 | 5 | 53a982869dbf14f6a948589be9f2f3df3b9a7e97 | |
| ToppCell | Club-club-3|World / Class top | 8.42e-05 | 172 | 115 | 5 | 34fbb82a2ec77dd183cf26b38edeb7e936b707bc | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Undifferentiated_Pleomorphic_Sarcoma-6|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 8.65e-05 | 173 | 115 | 5 | 7714d27e53b02af4e071154cf2ea001fab347235 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.89e-05 | 174 | 115 | 5 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.89e-05 | 178 | 115 | 5 | 6d9ecfaeb50d562899380de379ebf7b99fd8adc9 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.89e-05 | 178 | 115 | 5 | d3f518cd75b02e85d45cbb9b2eff30f0272512a8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.89e-05 | 178 | 115 | 5 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-04 | 180 | 115 | 5 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.04e-04 | 180 | 115 | 5 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-04 | 180 | 115 | 5 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-04 | 181 | 115 | 5 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 182 | 115 | 5 | f4b74c2756989812abe4e7055ec8918f69d56025 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 183 | 115 | 5 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-04 | 183 | 115 | 5 | dc9602bed3136db91faeffef177006246dc92743 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 184 | 115 | 5 | 0ba243cbf69b4fe6ae100a7f0314317bec38026c | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 1.16e-04 | 184 | 115 | 5 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 184 | 115 | 5 | 8c23945bafe8926f25836bc208115edd5214a2b0 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.16e-04 | 184 | 115 | 5 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 184 | 115 | 5 | 2a8338e94937686a148b5433515700ca0f674058 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 185 | 115 | 5 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 185 | 115 | 5 | 239cc5184825b3cc98638d4aec0a1de8e508d76c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.19e-04 | 185 | 115 | 5 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 186 | 115 | 5 | ac7a84b11b4550c4ac01eab370dc8ab88e4fb72b | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 1.28e-04 | 188 | 115 | 5 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 1.28e-04 | 188 | 115 | 5 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-04 | 189 | 115 | 5 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-04 | 189 | 115 | 5 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | facs-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-04 | 189 | 115 | 5 | bdf8db938aa0863c4fed6fa99dcffd63c8c20c31 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-04 | 189 | 115 | 5 | 40cbd679dc0548bf5207e1b033c0597886ad6fe1 | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 1.34e-04 | 190 | 115 | 5 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.34e-04 | 190 | 115 | 5 | e5625feb21915d4545cfad2659745ef180efcb1f | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.34e-04 | 190 | 115 | 5 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-04 | 190 | 115 | 5 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-04 | 191 | 115 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-04 | 191 | 115 | 5 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-04 | 191 | 115 | 5 | beb5bb42bd53bce01339da9110d374901548793c | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.38e-04 | 191 | 115 | 5 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-04 | 191 | 115 | 5 | 6609d85fd2577633dcc067507304a6f9e5865ca3 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 1.38e-04 | 191 | 115 | 5 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-04 | 191 | 115 | 5 | d4f535b06ad483448ab692e9900c872c78cbed60 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.38e-04 | 191 | 115 | 5 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 191 | 115 | 5 | f892f725a32e704cd18fec2f6d1db82993e7e79a | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.38e-04 | 191 | 115 | 5 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-04 | 191 | 115 | 5 | b5210de890d338602857b5907135705a507bc2b0 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.38e-04 | 191 | 115 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-04 | 192 | 115 | 5 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-04 | 192 | 115 | 5 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.41e-04 | 192 | 115 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-04 | 192 | 115 | 5 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-04 | 192 | 115 | 5 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-04 | 192 | 115 | 5 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-04 | 192 | 115 | 5 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 192 | 115 | 5 | 5876ff75e273a48e7ad8236423fb41e4ae4c0a91 | |
| ToppCell | facs-Lung-EPCAM-18m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 193 | 115 | 5 | b9ac74357435f2f24aaede62b2a1d31b5d96a12c | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.44e-04 | 193 | 115 | 5 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.44e-04 | 193 | 115 | 5 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 193 | 115 | 5 | fa45042d30f9cfeed10e23270a78f18551219cfa | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 193 | 115 | 5 | 59b8186d0221fba06a16157e9d148399ed801f38 | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 1.44e-04 | 193 | 115 | 5 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 193 | 115 | 5 | dc92680b4bb9fc26430c92e03adb839c8c3b3b98 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-04 | 193 | 115 | 5 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 193 | 115 | 5 | 03678162648bd5b1d65a5450b60c8863edbf95c7 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.44e-04 | 193 | 115 | 5 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 193 | 115 | 5 | ab511ea9e09216a965b3ae5a94f8c3c1ae33d944 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 194 | 115 | 5 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 194 | 115 | 5 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 194 | 115 | 5 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | 18-Airway-Epithelial-Secretory_progenitor|Airway / Age, Tissue, Lineage and Cell class | 1.48e-04 | 194 | 115 | 5 | 9a2efa50731135a178141aae55fa8b3e022c9904 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 195 | 115 | 5 | 79a6e8e6de040ff07539e8901fc407363a50e355 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.55e-04 | 196 | 115 | 5 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | facs-Heart-LA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 197 | 115 | 5 | 2a91738cb6d7588869dd00deeea0cbbc2d6aa34d | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.63e-04 | 198 | 115 | 5 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.63e-04 | 198 | 115 | 5 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 1.67e-04 | 199 | 115 | 5 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.71e-04 | 200 | 115 | 5 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-OPC_related-OPC|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.71e-04 | 200 | 115 | 5 | 02594c1edbc9f2cf831639cd83363abd2551cb94 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.71e-04 | 200 | 115 | 5 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.71e-04 | 200 | 115 | 5 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-OPC_related|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.71e-04 | 200 | 115 | 5 | 46521d83b917b0357601db8783c8da6b73730d60 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.71e-04 | 200 | 115 | 5 | a510deaada669e690329183e18df02870bd204b3 | |
| Drug | Pipenzolate bromide [125-51-9]; Up 200; 9.2uM; PC3; HT_HG-U133A | 5.96e-07 | 196 | 113 | 9 | 4484_UP | |
| Drug | Remoxipride Hydrochloride [73220-03-8]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 6.66e-06 | 198 | 113 | 8 | 5443_UP | |
| Disease | Microcytic anemia | 4.05e-05 | 3 | 109 | 2 | cv:C5194182 | |
| Disease | Timothy syndrome (implicated_via_orthology) | 8.07e-05 | 4 | 109 | 2 | DOID:0060173 (implicated_via_orthology) | |
| Disease | thiosulfate sulfurtransferase measurement | 2.01e-04 | 6 | 109 | 2 | EFO_0802130 | |
| Disease | pleckstrin homology domain-containing family A member 1 measurement | 2.81e-04 | 7 | 109 | 2 | EFO_0802873 | |
| Disease | mast/stem cell growth factor receptor kit measurement | 2.81e-04 | 7 | 109 | 2 | EFO_0020554 | |
| Disease | PAX-interacting protein 1 measurement | 3.73e-04 | 8 | 109 | 2 | EFO_0801868 | |
| Disease | C-C motif chemokine 3-like 1 measurement | 3.73e-04 | 8 | 109 | 2 | EFO_0008052 | |
| Disease | gdnf family receptor alpha-1 measurement | 3.73e-04 | 8 | 109 | 2 | EFO_0020400 | |
| Disease | zinc fingers and homeoboxes protein 3 measurement | 4.79e-04 | 9 | 109 | 2 | EFO_0803299 | |
| Disease | HLA class II histocompatibility antigen, DQ alpha 2 chain measurement | 4.79e-04 | 9 | 109 | 2 | EFO_0801686 | |
| Disease | age at menopause | 9.17e-04 | 302 | 109 | 6 | EFO_0004704 | |
| Disease | C-C motif chemokine 19 measurement | 1.20e-03 | 14 | 109 | 2 | EFO_0008047 | |
| Disease | apolipoprotein A 1 measurement | HLA-DQB2 ZRANB3 THOC5 LHCGR BMPR2 NFATC3 NANS STARD3 RRP7A SLC7A10 | 1.20e-03 | 848 | 109 | 10 | EFO_0004614 |
| Disease | gastroparesis | 1.57e-03 | 16 | 109 | 2 | EFO_1000948 | |
| Disease | Antibody Deficiency Syndrome | 1.77e-03 | 17 | 109 | 2 | C0003257 | |
| Disease | androstenedione measurement, estrone measurement | 1.99e-03 | 18 | 109 | 2 | EFO_0007970, EFO_0007972 | |
| Disease | lupus nephritis (is_implicated_in) | 1.99e-03 | 18 | 109 | 2 | DOID:0080162 (is_implicated_in) | |
| Disease | C-C motif chemokine 3 measurement | 1.99e-03 | 18 | 109 | 2 | EFO_0008051 | |
| Disease | Bone marrow hypocellularity | 1.99e-03 | 18 | 109 | 2 | C1855710 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 2.22e-03 | 19 | 109 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 2.22e-03 | 19 | 109 | 2 | C2936783 | |
| Disease | breast cancer (is_implicated_in) | 2.36e-03 | 150 | 109 | 4 | DOID:1612 (is_implicated_in) | |
| Disease | glaucoma (is_marker_for) | 2.46e-03 | 20 | 109 | 2 | DOID:1686 (is_marker_for) | |
| Disease | Deaf Mutism | 2.46e-03 | 20 | 109 | 2 | C4082305 | |
| Disease | Deafness, Acquired | 2.46e-03 | 20 | 109 | 2 | C0751068 | |
| Disease | Hearing Loss, Extreme | 2.46e-03 | 20 | 109 | 2 | C0086395 | |
| Disease | Complete Hearing Loss | 2.46e-03 | 20 | 109 | 2 | C0581883 | |
| Disease | Bilateral Deafness | 2.46e-03 | 20 | 109 | 2 | C3665473 | |
| Disease | Prelingual Deafness | 2.46e-03 | 20 | 109 | 2 | C0011052 | |
| Disease | Antihypertensive use measurement | 3.08e-03 | 265 | 109 | 5 | EFO_0009927 | |
| Disease | Immunologic Deficiency Syndromes | 3.25e-03 | 23 | 109 | 2 | C0021051 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NIVYPPCDVQTFLDI | 276 | Q2TAA5 | |
| VPFQVVCPVVYCSIV | 476 | Q9H172 | |
| VQEVPVPNEACAYLF | 131 | Q8TER5 | |
| PENAVLPLCFVVAVY | 181 | Q8WY22 | |
| TFSNYVLQPVFPNCI | 141 | Q9NS82 | |
| SQEIAVQVQAIPYPC | 1041 | Q86UK0 | |
| IFNSVLFDNICPTPI | 326 | Q96A70 | |
| YAGNTEPQFIIPSCI | 21 | Q9P1U1 | |
| IVFVIFEVPCPYQCL | 201 | Q8N4C9 | |
| IYPVVQAFCLQLPSF | 221 | Q5VUY2 | |
| QKFIVDYSETSPQCP | 41 | P55774 | |
| YTFIVPQQRVTGAIC | 56 | Q9UKU9 | |
| TFSLQYTPPVVACVC | 186 | O60563 | |
| TSCVNPPTVQNAYIV | 1046 | P08603 | |
| FSQICSYEIITPDVP | 196 | O94985 | |
| FSETPLLPCYNIQVS | 1641 | Q6W2J9 | |
| IEPQISYVTCNPTLD | 1061 | Q6DHV5 | |
| TYGFVLPEAQIQPTC | 316 | Q8IVL8 | |
| PIVYQECPVVPSSQV | 1631 | P59510 | |
| FLLTVCVQNPLGPDY | 411 | P52333 | |
| PLYPITVDVLYTVCN | 176 | Q8WVV9 | |
| PICAFQLPDLTVYNE | 131 | Q6GQQ9 | |
| PNVLDTFYCDVPQVL | 171 | Q8NGI4 | |
| TQYNPPFQSEDLILC | 391 | Q8WUM0 | |
| VFIPCTQVPLEVYLC | 306 | Q6TGC4 | |
| PNILDNFYCDVPQVL | 171 | P58180 | |
| PAPITECIFYTQSSL | 201 | Q8NGC9 | |
| PEVYVAFTVRNPETC | 276 | P0C5J1 | |
| YTIYLIPCTVQPTQP | 3606 | Q86XX4 | |
| PVPVVYSLNTEFQLC | 3651 | Q86XX4 | |
| VLLVLFYPINSCANP | 606 | P22888 | |
| PATCFEYPNFIRVVI | 406 | P17735 | |
| FLICIPPSEVTYQQT | 696 | Q4ZG55 | |
| ACVPPFTIEVKANTY | 86 | P50440 | |
| PSIIQDTVTLCSYPF | 641 | Q15034 | |
| PAVIEVLFNSYPQLC | 376 | Q6ZVZ8 | |
| APTKPLVTQQIEACY | 141 | Q8IYD8 | |
| IYTCQVEHPSLQSPI | 201 | P05538 | |
| INSSCDQPIGYPIFV | 1981 | Q96RV3 | |
| CVPEQTEYATIVFPS | 241 | Q15116 | |
| VIYLQCTIQSAPAPV | 331 | Q9HCI6 | |
| ENCVISETPLVLPYN | 961 | Q9UHC1 | |
| VQIVFLYSLPICGPN | 156 | Q8NH70 | |
| LSVFYTVCTPLLNPI | 271 | Q8NGD4 | |
| INPYRETVCFSVEPV | 121 | A6NFY4 | |
| PEVYVAFTVRNPETC | 276 | Q96G04 | |
| TCLDTFPPISYLNAI | 266 | P53602 | |
| VTQLYALPCVLSQTP | 846 | Q9UGL1 | |
| ESFNLCFYTSQVPVP | 306 | Q9H0R1 | |
| LAPTCAYVFQPELLV | 171 | Q9HCN3 | |
| GSLVCFPNTYQEIPL | 1106 | Q2PPJ7 | |
| FTPAVCFYQPGTTVL | 1071 | Q2VWP7 | |
| YLPCFQVLPLDQQLV | 271 | P51843 | |
| PNVLDTFYCDVPQVL | 171 | Q8NGE8 | |
| QIVPVPDVYNLVCVA | 921 | Q86YC2 | |
| PFLNPFILTFCNQTV | 281 | Q8N148 | |
| NSICTVYIEVLPPNN | 596 | Q96QU1 | |
| PPYVDFRVFCNLTSV | 1151 | A1KZ92 | |
| EVTFNKVCPFQPILY | 2501 | Q9P2D7 | |
| YAGNTEPQFIIPSCI | 21 | P61158 | |
| ILLVFYCPTATEQAP | 101 | Q9Y6K0 | |
| FPSEIIFQNYTPCEV | 101 | Q4G0P3 | |
| NCITTVPYSLIPTAF | 566 | Q9H0H3 | |
| ANCVALAIYIPFPED | 136 | Q13936 | |
| APGQYIQCFTVQPVL | 1401 | Q92608 | |
| QFYQIPGTCLLPEVT | 81 | O14595 | |
| YFCTIVQGQVAPPTR | 21 | Q05707 | |
| ACDVPEKYPQLFQVT | 346 | O75061 | |
| YEECVVTTTPPSIQN | 96 | Q13873 | |
| PYPDAFQCAVVDNLI | 711 | Q5VTJ3 | |
| CQLVPSTCFIYQPVA | 251 | A8MX34 | |
| PQTPECYSLFASVLI | 181 | Q8N4M1 | |
| LYNCLDFPAGVVPVT | 496 | O00519 | |
| APDICSNLYVFQPSL | 406 | Q8IXB1 | |
| VTEVIPNYSCLVFCP | 571 | Q8TDG4 | |
| ITPNLVIFTIPYSGC | 2166 | Q9UGM3 | |
| KLDFPAVTICNINPY | 91 | P51170 | |
| IFANCVALAIYIPFP | 136 | Q01668 | |
| CKIIQSYLFDPVQVP | 6 | Q8IY42 | |
| NSIPTPLSGQIVYVC | 466 | Q8WY07 | |
| NTTLERQTFYCVPVP | 121 | Q9BTE3 | |
| PNILDNFYCDVPQVL | 171 | Q15615 | |
| EFVYIACQGPLPTTV | 2276 | Q12923 | |
| PNQVDYFICDIPAVL | 176 | Q8NGC3 | |
| PSQLPNICVEIYTSL | 146 | Q6NXP6 | |
| CIFIYVRPVSNFPTD | 251 | Q8NH83 | |
| TIVSCFCPAYPINIV | 41 | B4DJY2 | |
| FCPAYPINIVALVFS | 46 | B4DJY2 | |
| FLVVALPYANSCANP | 296 | P32745 | |
| IPPLNIAYAAFCSSV | 121 | Q96RN1 | |
| AQEPCSLLYAPETFV | 531 | O14841 | |
| FLQCTSAYPLQPEDV | 181 | Q9NR45 | |
| TVDVDPKSPQYCQVI | 46 | Q13228 | |
| PQISQPSIVKVYDEC | 721 | Q96JS3 | |
| PVYGTEVLDFCTLPQ | 1916 | Q6ZRS2 | |
| CPAELVYQEVILQPE | 291 | Q14849 | |
| PLNATEFNYLCPAII | 281 | Q13433 | |
| TFVACQEQRLIYLPP | 271 | P78348 | |
| FVYDLVNSCVPGIPA | 91 | Q6UXS0 | |
| LFVLNVPPYCTEESL | 61 | Q9Y3A4 | |
| PNIIDSYFCDVPLVI | 171 | Q8NGC2 | |
| PVSVVNTTLPCVAYV | 251 | Q658P3 | |
| PVPYCSICQELLTFI | 116 | Q8WYR1 | |
| IQLPPYISQCDEVLQ | 106 | A1X283 | |
| LLQVPFSIPFYCNVA | 211 | Q8TBR7 | |
| CSPIVAQYLSLPTVF | 156 | P22309 | |
| FPFQYCVETDIPLKT | 326 | Q12968 | |
| YIQPICLPFDVFQIL | 186 | Q86WS5 | |
| EPVVYNPTTAAFICD | 656 | Q8NB14 | |
| PFVVSCINLAVPCIY | 661 | Q6UXY8 | |
| TLPIPLQETYDVCEQ | 116 | Q92558 | |
| ALFVPFYCSIPRVQV | 136 | Q8NBM4 | |
| LVQEYCSRLNIPFPF | 1001 | Q7Z2W7 | |
| VPVTSDCQYLFPAKV | 501 | Q13769 | |
| LQFSQIYPVVCVPSS | 66 | Q92575 | |
| DPFVLSVQPVVFQAC | 321 | Q8IU80 | |
| ACVPFLNPYTVQADL | 876 | Q5FWF4 | |
| IFNVEFYAVVPSIPC | 86 | Q9BTX1 |